IDEXX Laboratories
Prezzo: 560.88Società e modello di business
IDEXX Laboratories is a global leader in veterinary diagnostics and software solutions. The company develops and manufactures a range of products for animal health, including diagnostic tests, instruments, and software for veterinary practices. Its major business segments include Companion Animal Group, Livestock, and Poultry, with the primary revenue source coming from diagnostic products and services for pets and livestock. IDEXX also offers water testing solutions and diagnostic products for dairy and poultry industries.
Profilo di investimento
The investment profile of IDEXX Laboratories is more aligned with growth investors, given its focus on innovation and expansion in the veterinary diagnostics market. The company has shown consistent revenue growth, although it faces higher risk factors. Investors seeking a balanced approach may find it suitable, but the absence of dividends may deter those focused on income.
Metriche fondamentali (sperimentale)
- EPS (TTM) — utile per azione degli ultimi 12 mesi, $
- 13.67 OK
- Ricavi QoQ — crescita dei ricavi trimestre su trimestre
- 4.6% ↑
- Sorpresa EPS
- 1.8% in linea
- Volatilità 20g
- 1.7% stabile
Traccia in portafoglio
Grafico prezzo
| Data | Prima | Dopo | Motivo |
|---|---|---|---|
| 2026-06-13 02:40 | Vendi | Mantieni | Mixed performance; cautious due to negative momentum. |
| 2026-06-03 02:43 | Mantieni | Vendi | Weak momentum and high risk overshadow potential upside. |
| 2026-05-24 02:41 | Vendi | Mantieni | Weak momentum and high risk; cautious outlook advised. |
| Data | Analista | Action | Target | Prezzo allora |
|---|---|---|---|---|
| 2026-04-28 12:16 | UBS | Target abbassato | 730 → 640 | 569.167 |
| 2026-02-09 11:54 | Piper Sandler | Target abbassato | 775 → 750 | 644.61 |
| 2026-02-05 10:41 | Barclays | Target abbassato | 850 → 800 | 642.94 |
Ancora nulla